Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Zeropix vs Champix in Healthy Males
NCT03362008Phase 1Completed
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Start
- Jul 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of varenicline in nicotine dependence (2 arms), sponsored by Jeil Pharmaceutical Co., Ltd. Primary endpoints: Area Under the Curve to the last measurable concentration at 96 hours and Maximum Plasma Concentration at 96 hours. Started Jul 2017; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT03362008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03362008.